Excluded Studies
Appendix I
List of Exclusion Codes:
X1: Ineligible population
X2: Ineligible intervention
X3: Ineligible comparator
X4: Ineligible outcome
X5: Ineligible timing
X6: Ineligible study design
X7: Duplicate or superseded by paper publication
X8: Non-English full text
X9: Ineligible country
X10: Not primary research
1. Antonsen BT, Kvarstein EH, Urnes Ø, et al: Favourable outcome of long-term combined psychotherapy for patients with borderline personality disorder: six-year follow-up of a randomized study. Psychother Res 27(1):51–63, 2017 DOI: 10.1080/10503307.2015.1072283 26261865 Exclusion Code: X1.
2. Arnevik E, Wilberg T, Urnes O, et al: Psychotherapy for personality disorders: short-term day hospital psychotherapy versus outpatient individual therapy: a randomized controlled study. Eur Psychiatry 24(2):71–78, 2009 DOI: 10.1016/j.eurpsy.2008.09.004 19097870 Exclusion Code: X1.
3. Artusio E: Acceptance and commitment therapy for individuals with emotion regulation problems: a pilot study. ProQuest Information and Learning, 2021 Exclusion Code: X6.
4. Bales DL, Verheul R, Hutsebaut J: Barriers and facilitators to the implementation of mentalization-based treatment (MBT) for borderline personality disorder. Personal Ment Health 11(2):118–131, 2017 DOI: 10.1002/pmh.1368 28488379 Exclusion Code: X4.
5. Barnicot K, Crawford M: Conclusions and questions from a non-randomised comparison of routine clinical services implementing different treatment models for borderline personality disorder. Psychol Med 49(16):2812–2814, 2019 DOI: 10.1017/s0033291719002447 31551098 Exclusion Code: X6.
6. Bateman A, Fonagy P: Impact of clinical severity on outcomes of mentalisation-based treatment for borderline personality disorder. Br J Psychiatry 203(3):221–227, 2013 DOI: 10.1192/bjp.bp.112.121129 23887998 Exclusion Code: X6.
7. Bateman A, O’Connell J, Lorenzini N, et al: A randomised controlled trial of mentalization-based treatment versus structured clinical management for patients with comorbid borderline personality disorder and antisocial personality disorder. BMC Psychiatry 16(1):304, 2016 DOI: 10.1186/s12888-016-1000-9 27577562 Exclusion Code: X6.
8. Beck E, Bo S, Jørgensen MS, et al: Mentalization-based treatment in groups for adolescents with borderline personality disorder: a randomized controlled trial. J Child Psychol Psychiatry 61(5):594–604, 2020 DOI: 10.1111/jcpp.13152 31702058 Exclusion Code: X7.
9. Bellino S, Bozzatello P, Rocca G, et al: Efficacy of omega-3 fatty acids in the treatment of borderline personality disorder: a study of the association with valproic acid. J Psychopharmacol 28(2):125–132, 2014 DOI: 10.1177/0269881113510072 24196948 Exclusion Code: X2.
10. Bernard L, Walburg V: Efficacy of a brief cognitive-emotional group intervention for patients with borderline personality disorder. Psychologie Francaise 65(3):185–196, 2020 DOI: 10.1016/j.psfr.2019.11.001 Exclusion Code: X6.
11. Berthoud L, Pascual-Leone A, Caspar F, et al: Leaving distress behind: a randomized controlled study on change in emotional processing in borderline personality disorder. Psychiatry 80(2):139–154, 2017 DOI: 10.1080/00332747.2016.1220230 28767333 Exclusion Code: X6.
12. Boritz T, Barnhart R, McMain SF: The influence of posttraumatic stress disorder on treatment outcomes of patients with borderline personality disorder. J Pers Disord 30(3):395–407, 2016 DOI: 10.1521/pedi_2015_29_207 26305394 Exclusion Code: X6.
13. Bozzatello P, Rocca P, Bellino S: Combination of omega-3 fatty acids and valproic acid in treatment of borderline personality disorder: a follow-up study. Clin Drug Investig 38(4):367–372, 2018 DOI: 10.1007/s40261-017-0617-x 29302857 Exclusion Code: X2.
14. Buchheim A, Hörz-Sagstetter S, Doering S, et al: Change of unresolved attachment in borderline personality disorder: RCT study of transference-focused psychotherapy. Psychother Psychosom 86(5):314–316, 2017 DOI: 10.1159/000460257 28903103 Exclusion Code: X6.
15. Chapman AL, Rosenthal MZ, Dixon-Gordon KL, et al: Borderline personality disorder and the effects of instructed emotional avoidance or acceptance in daily life. J Pers Disord 31(4):483–502, 2017 DOI: 10.1521/pedi_2016_30_264 27617652 Exclusion Code: X6.
16. Coyle TN, Shaver JA, Linehan MM: On the potential for iatrogenic effects of psychiatric crisis services: the example of dialectical behavior therapy for adult women with borderline personality disorder. J Consult Clin Psychol 86(2):116–124, 2018 DOI: 10.1037/ccp0000275 29369662 Exclusion Code: X6.
17. Davidson KM, Tyrer P, Norrie J, et al: Cognitive therapy v. usual treatment for borderline personality disorder: prospective 6-year follow-up. Br J Psychiatry 197(6):456–462, 2010 DOI: 10.1192/bjp.bp.109.074286 21119151 Exclusion Code: X6.
18. Edel MA, Raaff V, Dimaggio G, et al: Exploring the effectiveness of combined mentalization-based group therapy and dialectical behaviour therapy for inpatients with borderline personality disorder: a pilot study. Br J Clin Psychol 56(1):1–15, 2017 DOI: 10.1111/bjc.12123 27897326 Exclusion Code: X2.
19. Einy S, Narimani M, Atadokht A, et al: Effectiveness of mentalization based therapy and cognitive-analytical therapy on improved object relationship of people with borderline personality disorder: a comparison. Payesh (Health Monitor) 17(3):98–110, 2018 Exclusion Code: X8.
20. Euler S, Stalujanis E, Allenbach G, et al: Dialectical behavior therapy skills training affects defense mechanisms in borderline personality disorder: an integrative approach of mechanisms in psychotherapy. Psychother Res 29(8):1074–1085, 2019 DOI: 10.1080/10503307.2018.1497214 30005584 Exclusion Code: X4.
21. Farrell JM, Shaw IA, Webber MA: Corrigendum to “A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial” [(J. Behav. Ther. Exp. Psychiatr.) 40 (2) (June 2009) 317–328]). J Behav Ther Exp Psychiatry 60:111, 2018 DOI: 10.1016/j.jbtep.2018.04.001 29680679 Exclusion Code: X7.
22. Flynn D, Kells M, Joyce M, et al: Dialectical behaviour therapy for treating adults and adolescents with emotional and behavioural dysregulation: study protocol of a coordinated implementation in a publicly funded health service. BMC Psychiatry 18(1):51, 2018 DOI: 10.1186/s12888-018-1627-9 29482538 Exclusion Code: X10.
23. Gleeson JF, Chanen A, Cotton SM, et al: Treating co-occurring first-episode psychosis and borderline personality: a pilot randomized controlled trial. Early Interv Psychiatry 6(1):21–29, 2012 DOI: 10.1111/j.1751-7893.2011.00306.x 22379625 Exclusion Code: X2.
24. Gray AS, Townsend ML, Bourke ME, et al: Effectiveness of a brief parenting intervention for people with borderline personality disorder: a 12-month follow-up study of clinician implementation in practice. Adv Ment Health 17(1):33–43, 2019 DOI: 10.1080/18387357.2018.1464887 Exclusion Code: X1.
25. Griffiths H, Duffy F, Duffy L, et al: Efficacy of mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry 19(1):167, 2019 DOI: 10.1186/s12888-019-2158-8 31170947 Exclusion Code: X1.
26. Harned MS, Gallop RJ, Valenstein-Mah HR: What changes when? The course of improvement during a stage-based treatment for suicidal and self-injuring women with borderline personality disorder and PTSD. Psychother Res 28(5):761–775, 2018 DOI: 10.1080/10503307.2016.1252865 27808001 Exclusion Code: X6.
27. Heerebrand SL, Bray J, Ulbrich C, et al: Effectiveness of dialectical behavior therapy skills training group for adults with borderline personality disorder. J Clin Psychol 77(7):1573–1590, 2021 DOI: 10.1002/jclp.23134 33821506 Exclusion Code: X6.
28. Hollander E, Swann AC, Coccaro EF, et al: Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatry 162(3):621–624, 2005 DOI: 10.1176/appi.ajp.162.3.621 15741486 Exclusion Code: X6.
29. Jariani M, Saaki M, Nazari H, Birjandi M: The effect of olanzapine and sertraline on personality disorder in patients with methadone maintenance therapy. Psychiatr Danub 22(4):544–547, 2010 21169896 Exclusion Code: X9.
30. Jørgensen CR, Bøye R, Andersen D, et al: Eighteen months post-treatment naturalistic follow-up study of mentalization-based therapy and supportive group treatment of borderline personality disorder: clinical outcomes and functioning. Nord Psychol 66(4):254–273, 2014 Exclusion Code: X6.
31. Juul S, Simonsen S, Poulsen S, et al: Detailed statistical analysis plan for the short-term versus long-term mentalisation-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder randomised clinical trial (MBT-RCT). Trials 22(1):497, 2021 DOI: 10.1186/s13063-021-05450-y 34321051 Exclusion Code: X6.
32. Keefe JR, Kim TT, DeRubeis RJ, et al: Treatment selection in borderline personality disorder between dialectical behavior therapy and psychodynamic psychiatric management. Psychol Med 51(11):1829–1837, 2021 DOI: 10.1017/s0033291720000550 32204742 Exclusion Code: X6.
33. Keller S, Stelmaszczyk K, Kolly S, et al: Change in biased thinking in a treatment based on the motive-oriented therapeutic relationship for borderline personality disorder. J Pers Disord 32(Suppl):75–92, 2018 DOI: 10.1521/pedi.2018.32.supp.75 29388899 Exclusion Code: X6.
34. Kellett S, Gausden J, Gaskell C: The effectiveness of cognitive analytic therapy for borderline personality disorder: utilizing a withdrawal experimental design to improve sensitivity to abandonment. Psychol Psychother 94(Suppl 1):96–119, 2021 DOI: 10.1111/papt.12278 32396677 Exclusion Code: X6.
35. Keng SL, Tan JX: Effects of brief mindful breathing and loving-kindness meditation on shame and social problem solving abilities among individuals with high borderline personality traits. Behav Res Ther 97:43–51, 2017 DOI: 10.1016/j.brat.2017.07.004 28710927 Exclusion Code: X1.
36. Keng SL, Tan HH: Effects of brief mindfulness and loving-kindness meditation inductions on emotional and behavioral responses to social rejection among individuals with high borderline personality traits. Behav Res Ther 100:44–53, 2018 DOI: 10.1016/j.brat.2017.11.005 29179024 Exclusion Code: X10.
37. Keng SL, Lee CSL, Eisenlohr-Moul TA: Effects of brief daily mindfulness practice on affective outcomes and correlates in a high BPD trait sample. Psychiatry Res 280:112485, 2019 DOI: 10.1016/j.psychres.2019.112485 31408773 Exclusion Code: X6.
38. Khalid-Khan S, Segal SC, Jopling EN, et al: Effectiveness of a modified dialectical behaviour therapy for adolescents within a stepped-care model. Int J Adolesc Med Health 30(2):1–7, 2016 27394042 Exclusion Code: X6.
39. Klein JP, Hauer-von Mauschwitz A, Berger T, et al: Effectiveness and safety of the adjunctive use of an internet-based self-management intervention for borderline personality disorder in addition to care as usual: results from a randomised controlled trial. BMJ Open 11(9):e047771, 2021 DOI: 10.1136/bmjopen-2020-047771 34497078 Exclusion Code: X2.
40. Knoblich N, Gundel F, Brückmann C, et al: DNA methylation of APBA3 and MCF2 in borderline personality disorder: potential biomarkers for response to psychotherapy. Eur Neuropsychopharmacol 28(2):252–263, 2018 DOI: 10.1016/j.euroneuro.2017.12.010 29274998 Exclusion Code: X4.
41. Kramer U, Pascual-Leone A, Berthoud L, et al: Assertive anger mediates effects of dialectical behaviour-informed skills training for borderline personality disorder: a randomized controlled trial. Clin Psychol Psychother 23(3):189–202, 2016 DOI: 10.1002/cpp.1956 25864773 Exclusion Code: X4.
42. Krantz LH, McMain S, Kuo JR: The unique contribution of acceptance without judgment in predicting nonsuicidal self-injury after 20-weeks of dialectical behaviour therapy group skills training. Behav Res Ther 104:44–50, 2018 DOI: 10.1016/j.brat.2018.02.006 29529508 Exclusion Code: X6.
43. Krause-Utz A, Walther JC, Schweizer S, et al: Effectiveness of an emotional working memory training in borderline personality disorder: a proof-of-principle study. Psychother Psychosom 89(2):122–124, 2020 DOI: 10.1159/000504454 31901902 Exclusion Code: X2.
44. Krawitz R, Miga EM: Cost-effectiveness of dialectical behaviour therapy for borderline personality disorder, in The Oxford Handbook of Dialectical Behaviour Therapy. Edited by Swales MA. New York, Oxford University Press, 2019, pp 497–513 Exclusion Code: X6.
45. Kvarstein EH, Pedersen G, Folmo E, et al: Mentalization-based treatment or psychodynamic treatment programmes for patients with borderline personality disorder: the impact of clinical severity. Psychol Psychother 92(1):91–111, 2019 DOI: 10.1111/papt.12179 29582581 Exclusion Code: X7.
46. Lin TJ, Ko HC, Wu JY, et al: The effectiveness of dialectical behavior therapy skills training group vs. cognitive therapy group on reducing depression and suicide attempts for borderline personality disorder in Taiwan. Arch Suicide Res 23(1):82–99, 2019 DOI: 10.1080/13811118.2018.1436104 29528807 Exclusion Code: X1.
47. Linehan MM, Schmidt H 3rd, Dimeff LA, et al: Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict 8(4):279–292, 1999 DOI: 10.1080/105504999305686 10598211 Exclusion Code: X1.
48. Marziali E, Munroe-Blum H, McCleary L: The contribution of group cohesion and group alliance to the outcome of group psychotherapy. Int J Group Psychother 47(4):475–497, 1997 DOI: 10.1080/00207284.1997.11490846 9314699 Exclusion Code: X6.
49. McMain SF, Fitzpatrick S, Boritz T, et al: Outcome trajectories and prognostic factors for suicide and self-harm behaviors in patients with borderline personality disorder following one year of outpatient psychotherapy. J Pers Disord 32(4):497–512, 2018 DOI: 10.1521/pedi_2017_31_309 28910214 Exclusion Code: X6.
50. Mehlum L, Tørmoen AJ, Ramberg M, et al: Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: a randomized trial. J Am Acad Child Adolesc Psychiatry 53(10):1082–1091, 2014 DOI: 10.1016/j.jaac.2014.07.003 25245352 Exclusion Code: X1.
51. Mendo-Cullell M, Arenas-Pijoan L, Forné C, et al: A pilot study of the efficacy of an adventure therapy programme on borderline personality disorder: a pragmatic controlled clinical trial. Personal Ment Health 15(3):159–172, 2021 DOI: 10.1002/pmh.1505 33569869 Exclusion Code: X2.
52. Molavi P, Aziziaram S, Basharpoor S, et al: Repeated transcranial direct current stimulation of dorsolateral-prefrontal cortex improves executive functions, cognitive reappraisal emotion regulation, and control over emotional processing in borderline personality disorder: a randomized, sham-controlled, parallel-group study. J Affect Disord 274:93–102, 2020 DOI: 10.1016/j.jad.2020.05.007 32469838 Exclusion Code: X5.
53. Morey LC, Lowmaster SE, Hopwood CJ: A pilot study of manual-assisted cognitive therapy with a therapeutic assessment augmentation for borderline personality disorder. Psychiatry Res 178(3):531–535, 2010 DOI: 10.1016/j.psychres.2010.04.055 20537722 Exclusion Code: X2.
54. Munroe-Blum H, Marziali E: A controlled trial of short-term group treatment for borderline personality disorder. J Pers Disord 9(3):190–198, 1995 Exclusion Code: X1.
55. Neacsiu AD, Rizvi SL, Linehan MM: Dialectical behavior therapy skills use as a mediator and outcome of treatment for borderline personality disorder. Behav Res Ther 48(9):832–839, 2010 DOI: 10.1016/j.brat.2010.05.017 20579633 Exclusion Code: X4.
56. Neacsiu AD, Lungu A, Harned MS, et al: Impact of dialectical behavior therapy versus community treatment by experts on emotional experience, expression, and acceptance in borderline personality disorder. Behav Res Ther 53:47–54, 2014 DOI: 10.1016/j.brat.2013.12.004 24418652 Exclusion Code: X4.
57. Norrie J, Davidson K, Tata P, et al: Influence of therapist competence and quantity of cognitive behavioural therapy on suicidal behaviour and inpatient hospitalisation in a randomised controlled trial in borderline personality disorder: further analyses of treatment effects in the BOSCOT study. Psychol Psychother 86(3):280–293, 2013 DOI: 10.1111/papt.12004 23420622 Exclusion Code: X6.
58. O’Dwyer N, Rickwood D, Buckmaster D, et al: Therapeutic interventions in Australian primary care, youth mental health settings for young people with borderline personality disorder or borderline traits. Borderline Personal Disord Emot Dysregul 7:23, 2020 DOI: 10.1186/s40479-020-00138-2 33042549 Exclusion Code: X6.
59. Pahwa M, Nuñez NA, Joseph B, et al: Efficacy and tolerability of lamotrigine in borderline personality disorder: a systematic review and meta-analysis. Psychopharmacol Bull 50(4):118–136, 2020 33012875 Exclusion Code: X6.
60. Paret C, Niedtfeld I, Lotter T, et al: Single-dose effects of citalopram on neural responses to affective stimuli in borderline personality disorder: a randomized clinical trial. Biol Psychiatry Cogn Neurosci Neuroimaging 6(8):837–845, 2021 DOI: 10.1016/j.bpsc.2021.02.002 33607327 Exclusion Code: X5.
61. Priebe S, Bhatti N, Barnicot K, et al: Effectiveness and cost-effectiveness of dialectical behaviour therapy for self-harming patients with personality disorder: a pragmatic randomised controlled trial. Psychother Psychosom 81(6):356–365, 2012 DOI: 10.1159/000338897 22964561 Exclusion Code: X1.
62. Ramseyer F, Ebert A, Roser P, et al: Exploring nonverbal synchrony in borderline personality disorder: a double-blind placebo-controlled study using oxytocin. Br J Clin Psychol 59(2):186–207, 2020 DOI: 10.1111/bjc.12240 31774581 Exclusion Code: X1.
63. Rathus JH, Miller AL: Dialectical behavior therapy adapted for suicidal adolescents. Suicide Life Threat Behav 32(2):146–157, 2002 DOI: 10.1521/suli.32.2.146.24399 12079031 Exclusion Code: X1.
64. Reyes-López J, Ricardo-Garcell J, Armas-Castañeda G, et al: Clinical improvement in patients with borderline personality disorder after treatment with repetitive transcranial magnetic stimulation: preliminary results. Br J Psychiatry 40(1):97–104, 2018 DOI: 10.1590/1516-4446-2016-2112 28614492 Exclusion Code: X9.
65. Reyes-Ortega MA, Miranda EM, Fresán A, et al: Clinical efficacy of a combined acceptance and commitment therapy, dialectical behavioural therapy, and functional analytic psychotherapy intervention in patients with borderline personality disorder. Psychol Psychother 93(3):474–489, 2020 DOI: 10.1111/papt.12240 31246370 Exclusion Code: X9.
66. Ridolfi ME, Rossi R, Occhialini G, et al: A clinical trial of a psychoeducation group intervention for patients with borderline personality disorder. J Clin Psychiatry 81(1):19m12753, 2019 DOI: 10.4088/JCP.19m12753 31917907 Exclusion Code: X5.
67. Ridolfi ME, Rossi R, Occhialini G, et al: A randomized controlled study of a psychoeducation group intervention for patients with borderline personality disorder. J Clin Psychiatry 81(1):19m12753, 2020 Exclusion Code: X5.
68. Rinne T, van den Brink W, Wouters L, et al: SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 159(12):2048–2054, 2002 DOI: 10.1176/appi.ajp.159.12.2048 12450955 Exclusion Code: X2.
69. Rohde C, Polcwiartek C, Correll CU, et al: Real-world effectiveness of clozapine for borderline personality disorder: results from a 2-year mirror-image study. J Pers Disord 32(6):823–837, 2018 DOI: 10.1521/pedi_2017_31_328 29120277 Exclusion Code: X6.
70. Rossouw TI, Fonagy P: Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 51(12):1304–1313.e3, 2012 DOI: 10.1016/j.jaac.2012.09.018 23200287 Exclusion Code: X1.
71. Ryberg W, Diep LM, Landrø NI, et al: Effects of the Collaborative Assessment and Management of Suicidality (CAMS) model: a secondary analysis of moderation and influencing factors. Arch Suicide Res 24(4):589–608, 2020 DOI: 10.1080/13811118.2019.1650143 31442105 Exclusion Code: X10.
72. Sahin Z, Vinnars B, Gorman BS, et al: Clinical severity as a moderator of outcome in psychodynamic and dialectical behavior therapies for borderline personality disorder. Personal Disord 9(5):437–446, 2018 DOI: 10.1037/per0000276 29239627 Exclusion Code: X6.
73. Salamin V, Kratzel A, Gothuey I, et al: Compliant patients with borderline personality disorder non-responsive to one-year dialectical behavior therapy: outcomes of a second year. J Behav Cogn Ther 31(2):115–124, 2021 DOI: 10.1016/j.jbct.2021.01.001 Exclusion Code: X3.
74. Santamarina Perez P, Romero Cela S, Mendez Blanco I, et al: Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behavior. Eur Neuropsychopharmacol 27:S853–S4, 2017 Exclusion Code: X1.
75. Schilling L, Moritz S, Kriston L, et al: Efficacy of metacognitive training for patients with borderline personality disorder: preliminary results. Psychiatry Res 262:459–464, 2018 DOI: 10.1016/j.psychres.2017.09.024 28927866 Exclusion Code: X2.
76. Shafti SS, Shahveisi B: Olanzapine versus haloperidol in the management of borderline personality disorder: a randomized double-blind trial. J Clin Psychopharmacol 30(1):44–47, 2010 DOI: 10.1097/JCP.0b013e3181c826ff 20075647 Exclusion Code: X9.
77. Signer S, Estermann Jansen R, Sachse R, et al: Social interaction patterns, therapist responsiveness, and outcome in treatments for borderline personality disorder. Psychol Psychother 93(4):705–722, 2020 DOI: 10.1111/papt.12254 31583805 Exclusion Code: X6.
78. Sinyor M, Williams M, Mitchell R, et al: Cognitive behavioral therapy for suicide prevention in youth admitted to hospital following an episode of self-harm: a pilot randomized controlled trial. J Affect Disord 266:686–694, 2020 DOI: 10.1016/j.jad.2020.01.178 32056945 Exclusion Code: X1.
79. Smith EG: An opportunity to report closer-to-efficacy findings in a study of lamotrigine for borderline personality disorder. Am J Psychiatry 175(12):1265, 2018 DOI: 10.1176/appi.ajp.2018.18080991 30501419 Exclusion Code: X6.
80. Snoek A, Beekman ATF, Dekker J, et al: A randomized controlled trial comparing the clinical efficacy and cost-effectiveness of eye movement desensitization and reprocessing (EMDR) and integrated EMDR-dialectical behavioural therapy (DBT) in the treatment of patients with post-traumatic stress disorder and comorbid (sub)clinical borderline personality disorder: study design. BMC Psychiatry 20(1):396, 2020 DOI: 10.1186/s12888-020-02713-x 32762677 Exclusion Code: X6.
81. Soler J, Elices M, Pascual JC, et al: Effects of mindfulness training on different components of impulsivity in borderline personality disorder: results from a pilot randomized study. Borderline Personal Disord Emot Dysregul 3:1, 2016 DOI: 10.1186/s40479-015-0035-8 26759718 Exclusion Code: X6.
82. St-Amour S, Cailhol L, Ruocco AC, et al: Could physical exercise be an effective treatment for adults with borderline personality disorder? Psychiatry Res 295:113625, 2021 DOI: 10.1016/j.psychres.2020.113625 33302133 Exclusion Code: X2.
83. Thompson-Brenner H, Shingleton RM, Thompson DR, et al: Focused vs. broad enhanced cognitive behavioral therapy for bulimia nervosa with comorbid borderline personality: a randomized controlled trial. Int J Eat Disord 49(1):36–49, 2016 DOI: 10.1002/eat.22468 26649812 Exclusion Code: X1.
84. Tong K, Costello S, McCabe E, et al: Mentalization-based treatment in a naturalistic setting in Ireland: a cohort study. Psychiatr Serv 73(1):46–52, 2022 DOI: 10.1176/appi.ps.202000810 34106745 Exclusion Code: X4
85. Turner RM: Naturalistic evaluation of dialectical behavior therapy-oriented treatment for borderline personality disorder. Cogn Behav Pract 7(4):413–419, 2000 Exclusion Code: X2.
86. Vita A, Deste G, Barlati S, et al: Feasibility and effectiveness of cognitive remediation in the treatment of borderline personality disorder. Neuropsychol Rehabil 28(3):416–428, 2018 DOI: 10.1080/09602011.2016.1148054 26872501 Exclusion Code: X2.
87. Waltz J, Dimeff LA, Koerner K, et al: Feasibility of using video to teach a dialectical behavior therapy skill to clients with borderline personality disorder. Cogn Behav Pract 16(2):214–222, 2009 DOI: 10.1016/j.cbpra.2008.08.004 Exclusion Code: X4.
88. Wolkenstein L, Rombold-Bruehl F, Bingmann T, et al: Challenging control over emotions in borderline personality disorder - a tDCS study. Neuropsychologia 156:107850, 2021 DOI: 10.1016/j.neuropsychologia.2021.107850 33812945 Exclusion Code: X4.
89. Wong MT, Tye C: Low hospital inpatient readmission rate in patients with borderline personality disorder: a naturalistic study at Southern Health, Victoria, Australia. Aust N Z J Psychiatry 39(7):607–611, 2005 DOI: 10.1080/j.1440-1614.2005.01633.x 15996142 Exclusion Code: X4.
90. Zanarini MC, Schulz SC, Detke H, et al: Open-label treatment with olanzapine for patients with borderline personality disorder. J Clin Psychopharmacol 32(3):398–402, 2012 DOI: 10.1097/JCP.0b013e3182524293 22544004 Exclusion Code: X3.
91. Zeifman RJ, Boritz T, Barnhart R, et al: The independent roles of mindfulness and distress tolerance in treatment outcomes in dialectical behavior therapy skills training. Personal Disord 11(3):181–190, 2020 DOI: 10.1037/per0000368 31647267 Exclusion Code: X6.
92. Ziegenhorn AA, Roepke S, Schommer NC, et al: Clonidine improves hyperarousal in borderline personality disorder with or without comorbid posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 29(2):170–173, 2009 DOI: 10.1097/JCP.0b013e31819a4bae 19512980 Exclusion Code: X2.
Information & Authors
Information
Published In
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Borderline Personality Disorder
November 2024
©American Psychiatric Association Publishing
Authors
Metrics & Citations
Metrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).